Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of nifedipine (Adalat) on platelet function in vitro and in vivo.

× No keyword cloud information.

16 in total

1. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.

Authors: A Lückhoff; M Bohnert; R Busse
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1991-01 Impact factor: 3.000

2. Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?

Authors: W Schneider; G Kober; P Roebruck; H Noack; M Alle; G Cieslinski; N Reifart; M Kaltenbach
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

Review 3. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors: E M Sorkin; S P Clissold; R N Brogden
Journal: Drugs Date: 1985-09 Impact factor: 9.546

4. Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.

Authors: S E Akopov; E S Gabrielian
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

Review 5. Treatment of persistent pulmonary hypertension of the newborn: update.

Authors: Y K Abu-Osba
Journal: Arch Dis Child Date: 1991-01 Impact factor: 3.791

6. The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.

Authors: J L Francis; O S Roath; V F Challenor; D G Waller
Journal: Br J Clin Pharmacol Date: 1988-06 Impact factor: 4.335

7. The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin.

Authors: M B Murphy; M A Orchard; E L Conway; S E Barrow
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

Review 8. Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors: K J Tietze; M L Schwartz; P H Vlasses
Journal: Drugs Date: 1987-06 Impact factor: 9.546

9. Inhibition of rat mast cell degranulation by verapamil.

Authors: A Legrand; J Cerrina; C Bonne; A Lockhart; J Benveniste
Journal: Agents Actions Date: 1984-02

10. Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation.

Authors: M Hahn; V A Tkachuk; V N Bochkov; I B Cheglakov; J P Clozel
Journal: Cardiovasc Drugs Ther Date: 1995-12 Impact factor: 3.727